Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double‐blind, 8‐week study

G. Cheung, Deanna; Aizenberg, Diego; М. Горбунов, В.; Hafeez, Kudsia; Chen, Chien‐Wei; Zhang, Jack

doi:10.1111/jch.13153

Public

Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double‐blind, 8‐week study

Published in Journal of Clinical Hypertension • Jan 1, 2018

Authors:

Deanna G. Cheung

Diego Aizenberg

В. М. Горбунов

Abstract

A majority of patients with hypertension fail to achieve blood pressure (BP) control despite treatment with commonly prescribed drugs. This randomized, double-blind phase III trial assessed the superiority of sacubitril/valsartan 200 mg (97/103 mg) to continued olmesartan 20 mg in reducing ambulator...

Subject

Olmesartan

Medicine

Sacubitril

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!